Two North American companies have announced collaborations with established drug delivery firms to produce and expand distribution for oral CBD strips – soluble strips that dissolve in the mouth.

Tilray, one of the largest cannabis companies, has signed a licence, development and supply agreement with IntelGenx, an oral drug delivery company. Together the two Canadian companies will fund, develop and commercialise an oral film product with medical cannabis and adult-use purposes.

Meanwhile, California-based Chemesis International will partner Rapid Dose Therapeutics, a Canadian biotechnology company, to distribute QuickStrips Oral Thin Strips in California and Puerto Rico.

Read full article
I'm already a subscriber

Freddie Dawson

Managing editor, news
Freddie studied at King’s College, London and City University and worked for publications including The Times, The Malay Mail, PathfinderBuzz and Solar Summary before joining the ECigIntelligence team. He has extensive experience in covering fast-moving consumer goods (FMCG), manufacturing and technological innovation.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization